β-Hydroxyamphetamine
| β-Hydroxyamphetamine | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 151.21 g/mol [1] |
| Melting point | 190-194 °C [1] |
| Solubility | Freely soluble [1] |
| Predicted LogP | 0.8 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C9H13NO |
| IUPAC name | 2-amino-1-phenylpropan-1-ol |
| SMILES | CC(C(C1=CC=CC=C1)O)N |
| InChI | InChI=1S/C9H13NO/c1-7(10)9(11)8-5-3-2-4-6-8/h2-7,9,11H,10H2,1H3 |
| InChIKey | DLNKOYKMWOXYQA-UHFFFAOYSA-N |
| CAS number | 48115-38-4 |
| PubChem CID | 4786 |
β-Hydroxyamphetamine (also known as 2-Amino-1-phenyl-1-propanol, 628-077-1, α-(1-aminoethyl)benzyl alcohol, 2-Amino-2-methyl-1-phenylethanol, 2-Amino-1-hydroxy-1-phenylpropane, β-Hydroxy-α-methylphenethylamine, Benzenemethanol, α-(1-aminoethyl)-, Benzenemethanol, a-(1-aminoethyl)-, Dexatrim or (-)-Pseudo Norephedrine) is a stimulant substance of the amphetamine and phenylethanolamine class.
Chemistry
Stereochemistry []
β-Hydroxyamphetamine is a racemic mixture of the diastereomers.
Druglikeness
Lipinski's rule of five
β-Hydroxyamphetamine matches Lipinski's rule of five.Pharmacology
Mechanism of action []
Phenylpropanolamine acts directly on alpha- and, to a lesser degree, beta-adrenergic receptors in the mucosa of the respiratory tract. Stimulation of alpha-adrenergic receptors produces vasoconstriction, reduces tissue hyperemia, edema, and nasal congestion, and increases nasal airway patency. PPA indirectly stimulates beta-receptors, producing tachycardia and a positive inotropic effect. [1]
Medical side effects []
40 side effects listed on drug labels in SIDER 4.1 (phenylpropanolamine).
- Anxiety
- Arrhythmia
- Ataxia
- Confusional state
- Feeling abnormal
- Constipation
- Dizziness
- Somnolence
- Dyskinesia
- Dyspnoea
- Dermatitis
- Rash
- Flushing
- Hallucination
- Hypersensitivity
- Hypotension
- Irritability
- Renal tubular necrosis
- Nausea
- Nervousness
- Tension
- Psychotic disorder
- Tachycardia
- Tremor
- Vomiting
- Urinary retention
- Agitation
- Hepatocellular injury
- Liver injury
- Urinary hesitation
- Dysphoria
- Respiratory depression
- Pulmonary function test decreased
- Euphoric mood
- Vision blurred
- Blood pressure increased
- Coordination abnormal
- Antitussive therapy
- Serotonin syndrome
- Insomnia
Indications
- Ache
- Body temperature increased
- Common cold
- Cough
- Discomfort
- Headache
- Hypersensitivity
- Nasal congestion
- Pain
- Rhinorrhoea
- Seasonal allergy
- Sinusitis
- Sneezing
Subjective effects []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 4786, β-Hydroxyamphetamine. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/4786
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 09:00:18 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 09:00:14 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 09:00:14 |
| gsrs | missing (no UNII) | 2026-11-20 09:00:14 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0243518) | 2026-11-20 09:00:14 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 09:00:18 |
| pubchem | ok | 2026-11-20 09:00:10 |
| missing (no r/tripreports posts mention it) | 2026-11-20 09:00:14 | |
| sider | ok | 2026-11-20 09:00:14 |
| structure | ok | 2026-11-20 09:00:14 |
| wikipedia | missing (no Wikipedia article with a drug infobox) | 2026-11-20 09:00:14 |